CINECA IRIS Institutional Research Information System

MARTELLI, ALMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.446
EU - Europa 4.035
AS - Asia 1.315
AF - Africa 166
SA - Sud America 13
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.182
IT - Italia 1.682
SE - Svezia 687
CN - Cina 652
DE - Germania 471
BG - Bulgaria 401
CA - Canada 262
VN - Vietnam 209
GB - Regno Unito 171
TR - Turchia 146
AT - Austria 138
SG - Singapore 135
CI - Costa d'Avorio 124
FI - Finlandia 111
FR - Francia 95
UA - Ucraina 78
HK - Hong Kong 55
PL - Polonia 55
RU - Federazione Russa 51
IN - India 48
SN - Senegal 27
BE - Belgio 24
CH - Svizzera 24
JP - Giappone 18
NL - Olanda 14
AU - Australia 11
NG - Nigeria 10
IR - Iran 9
KR - Corea 9
GR - Grecia 7
PK - Pakistan 7
IQ - Iraq 6
BR - Brasile 5
CL - Cile 5
TW - Taiwan 5
EU - Europa 4
HU - Ungheria 4
LU - Lussemburgo 4
UZ - Uzbekistan 4
DK - Danimarca 3
ES - Italia 3
GH - Ghana 2
HR - Croazia 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
MX - Messico 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ID - Indonesia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
VE - Venezuela 1
Totale 13.992
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.142
Ann Arbor 968
Fairfield 901
Chandler 734
Houston 666
Ashburn 536
Serra 488
Sofia 401
Seattle 396
Milan 355
Wilmington 335
Cambridge 302
Beijing 269
Ottawa 244
New York 231
Princeton 172
Lawrence 157
Vienna 132
Izmir 131
Medford 126
Abidjan 124
Nanjing 121
Jacksonville 110
Frankfurt am Main 108
Dong Ket 106
Des Moines 90
London 65
Pisa 59
Florence 58
San Diego 55
Rome 52
Warsaw 52
Hong Kong 43
Dearborn 42
Marseille 42
Boulder 41
Redwood City 40
Nanchang 36
Ogden 35
Dakar 27
Washington 27
Boardman 24
Los Angeles 24
Nürnberg 24
Shenyang 24
Brussels 23
Bremen 22
Changsha 20
Kunming 20
Livorno 20
Bern 19
Jüchen 19
Tianjin 19
Grafing 18
Norwalk 18
Auburn Hills 16
Falls Church 16
Hebei 16
Lancaster 16
Guangzhou 15
Pune 15
Chicago 14
Jiaxing 14
Hangzhou 13
Vicopisano 13
Hefei 12
Napoli 12
Lagos 10
Shanghai 9
Jinan 8
Pessac 7
Scafati 7
Alessandria 6
Amsterdam 6
Bologna 6
Carrara 6
Detroit 6
Helsinki 6
Islamabad 6
Mumbai 6
Naples 6
Orange 6
Phoenix 6
Tokyo 6
Toronto 6
Canberra 5
Central District 5
Grosseto 5
Indiana 5
Istanbul 5
Lucca 5
Massa Marittima 5
San Francisco 5
Singapore 5
Capannori 4
Cascina 4
Caserta 4
Chengdu 4
Columbus 4
Council Bluffs 4
Totale 10.673
Salva come PNG Salva come JPEG
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 263
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 216
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 210
Vascular Effects of p-Carboxyphenyl-Isothiocyanate, a novel H2S-donor 192
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 176
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 173
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 171
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 168
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 163
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 163
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 160
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 158
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 157
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 155
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 151
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 149
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 148
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 146
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 143
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 139
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 137
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 135
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 133
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 132
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 131
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 131
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 130
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 129
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 129
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 129
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 127
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 127
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 126
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 126
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 124
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 121
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 121
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 119
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 119
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 117
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 116
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 116
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 115
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 109
Evaluation of the NO-releasing properties of NO-donor linkers 109
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 109
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 108
Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener 107
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 106
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 105
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 104
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 103
New amido derivatives as potential BKCa potassium channel activators. XI 103
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 103
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 102
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 102
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 101
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 100
null 98
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 96
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 94
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 94
NO-Releasing Hybrids of Cardiovascular Drugs 93
IMPROVING THE SOLUBILITY OF A NEW CLASS OF ANTIINFLAMMATORY PHARMACODYNAMIC HYBRIDS, THAT RELEASE NITRIC OXIDE AND INHIBIT CYCLOXYGENASE-2 ISOENZYME 93
null 92
null 92
EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL 91
NO-releasing hybrids of cardiovascular drugs 91
QSAR Studies on BK Channel Activators 91
null 91
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 91
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 91
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 90
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 89
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 89
Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties 88
In-vitro evaluation of new pharmacodynamic hybrids with insulin secretagogue and NO-donor activity 87
Enantioselectivity in Cardioprotection induced by (S)- (-)-2,2-Dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromane 86
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 86
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: DIARYLPYRROLE ACETIC ACID ESTERS ENDOWED WITH NITRIC OXIDE RELEASING PROPERTIES 86
(+/-)-NARINGENIN AS KCA 1.1 CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 85
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 85
Anti-ischemic properties of new spiro-morpholine benzopyrane derivatives, potential activators of mitochondrial atp-sensitive potassium channel, on isolated rat hearts 84
SYNTHESIS AND BIOLOGICAL EVALUATION OF 5-MEMBERED SPIRO HETEROCYCLE-BENZIPYRAN DERIVATIVES AGAINST MYOCARDIAL ISCHEMIA 84
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 83
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 81
Cardioprotective effects of different flavonoids against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts. 80
null 79
Pharmacodynamic hybrids with insulin secretagogue and NO-Donor activity 78
null 78
Efficacy of isothiocyanate-based compounds on different forms of persistent pain 78
ROLE OF MITOCHONDRIAL BK POTASSIUM CHANNELS IN THE CARDIOPROTECTIVE EFFECTS OF FLAVONOIDS AGAINST ISCHEMIA/REPERFUSION INJURY 77
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 77
CARDIOVASCULAR EFFECTS OF A NEW NO-RELEASING COXIB DERIVATIVE 76
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 76
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 76
EFFECTS OF KATP OPENERS ON THE QT PROLONGATION INDUCED BY HERG-BLOCKING DRUGS IN GUINEA-PIGS 73
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 72
Vascular effects of H2S-donors: Fluorimetric detection of H2S generation and ion channel activation in human aortic smooth muscle cells 72
ACTIVATORS OF CARDIAC MITOCHONDRIAL ATP SENSITIVE POTASSIUM CHANNELS: PROMISING DRUGS FOR ANTIISCHAEMIC THERAPY. 70
Totale 11.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019548 0 0 0 0 0 0 0 0 0 0 316 232
2019/20202.617 321 198 258 166 215 268 292 210 244 177 200 68
2020/20211.395 108 86 70 64 100 118 68 127 182 99 105 268
2021/20221.811 36 137 51 77 300 289 54 95 89 59 137 487
2022/20232.582 297 340 166 211 266 342 20 169 549 17 122 83
2023/20241.645 161 232 223 109 269 335 98 54 30 40 94 0
Totale 14.489